GOSS
Price
$0.77
Change
+$0.03 (+4.05%)
Updated
May 6, 1:28 PM EST
8 days until earnings call
RYTM
Price
$44.25
Change
+$0.49 (+1.12%)
Updated
May 6, 1:47 PM EST
One day until earnings call
Ad is loading...

GOSS vs RYTM ᐉ Comparison: Which is Better to Invest?

Header iconGOSS vs RYTM Comparison
Open Charts GOSS vs RYTMBanner chart's image
Gossamer Bio
Price$0.77
Change+$0.03 (+4.05%)
Volume$5.4K
CapitalizationN/A
Rhythm Pharmaceuticals
Price$44.25
Change+$0.49 (+1.12%)
Volume$501
CapitalizationN/A
View a ticker or compare two or three
GOSS vs RYTM Comparison Chart

Loading...

GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RYTMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GOSS vs. RYTM commentary
May 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and RYTM is a Hold.

COMPARISON
Comparison
May 06, 2024
Stock price -- (GOSS: $0.74 vs. RYTM: $43.76)
Brand notoriety: GOSS and RYTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 283% vs. RYTM: 166%
Market capitalization -- GOSS: $167.4M vs. RYTM: $2.67B
GOSS [@Biotechnology] is valued at $167.4M. RYTM’s [@Biotechnology] market capitalization is $2.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $545.88B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileRYTM’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • RYTM’s FA Score: 0 green, 5 red.
According to our system of comparison, both GOSS and RYTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while RYTM’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 4 bearish.
  • RYTM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GOSS and RYTM are a good buy in the short-term.

Price Growth

GOSS (@Biotechnology) experienced а +10.78% price change this week, while RYTM (@Biotechnology) price change was +14.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.95%. For the same industry, the average monthly price growth was -3.09%, and the average quarterly price growth was +64.79%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 06, 2024.

RYTM is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Biotechnology (+3.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for GOSS with price predictions.
OPEN
A.I.dvisor published
a Summary for RYTM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RYTM($2.67B) has a higher market cap than GOSS($167M). RYTM YTD gains are higher at: -4.807 vs. GOSS (-18.904).
GOSSRYTMGOSS / RYTM
Capitalization167M2.67B6%
EBITDAN/AN/A-
Gain YTD-18.904-4.807393%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
53
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSRYTM
RSI
ODDS (%)
Bullish Trend 4 days ago
69%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 12 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 6 days ago
81%
View a ticker or compare two or three
Ad is loading...
GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RYTMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLMGX40.510.53
+1.33%
Harding Loevner Global Equity Advisor
RMFBX52.150.52
+1.01%
American Funds American Mutual R2
TINCX2.480.02
+0.81%
Templeton Global Balanced A1
FMBRX16.280.10
+0.62%
Franklin Mutual Beacon R6
OFSCX18.270.07
+0.38%
Olstein Strategic Opportunities C

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-4.06%
MEIP - GOSS
46%
Loosely correlated
N/A
CGEM - GOSS
45%
Loosely correlated
+2.79%
VIR - GOSS
44%
Loosely correlated
+13.18%
SYRE - GOSS
41%
Loosely correlated
-1.35%
APVO - GOSS
41%
Loosely correlated
-12.48%
More

RYTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with FOLD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then FOLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
+6.78%
FOLD - RYTM
36%
Loosely correlated
-0.29%
PCVX - RYTM
35%
Loosely correlated
+2.18%
KALV - RYTM
34%
Loosely correlated
-0.33%
DNLI - RYTM
33%
Loosely correlated
+1.96%
KURA - RYTM
33%
Loosely correlated
+0.19%
More